BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 8114738)

  • 1. D-type cyclin-dependent kinase activity in mammalian cells.
    Matsushime H; Quelle DE; Shurtleff SA; Shibuya M; Sherr CJ; Kato JY
    Mol Cell Biol; 1994 Mar; 14(3):2066-76. PubMed ID: 8114738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
    Quelle DE; Ashmun RA; Shurtleff SA; Kato JY; Bar-Sagi D; Roussel MF; Sherr CJ
    Genes Dev; 1993 Aug; 7(8):1559-71. PubMed ID: 8339933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
    Kato JY; Sherr CJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11513-7. PubMed ID: 7505440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Meyerson M; Harlow E
    Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
    Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D-type cyclins and their role in tumorigenesis.
    Peters G
    J Cell Sci Suppl; 1994; 18():89-96. PubMed ID: 7883799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.
    Kato JY; Matsuoka M; Strom DK; Sherr CJ
    Mol Cell Biol; 1994 Apr; 14(4):2713-21. PubMed ID: 8139570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
    Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
    Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
    Matsushime H; Ewen ME; Strom DK; Kato JY; Hanks SK; Roussel MF; Sherr CJ
    Cell; 1992 Oct; 71(2):323-34. PubMed ID: 1423597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.
    Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S
    J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
    Dey A; Li W
    Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.